47m
Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit ...
Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback